Cancer incidence and mortality in the Metropolitan Area of Bucaramanga, Colombia, 2013-2017
Keywords:
Incidence, Mortality, Neoplasms, Public Health Surveillance, Population Health, Registries, ColombiaArticle Sidebar
Main Article Content
Introduction
Cancer is a global public health problem. Population-Based Cancer Registries (PBCRs) are essential tools for characterizing the epidemiology of the disease and evaluating the impact of public health interventions aimed at controlling it.
Aim
To estimate cancer incidence and mortality in the Metropolitan Area of Bucaramanga (AMB) during 2013-2017.
Methods
Descriptive retrospective population-based study of incidence and mortality. Invasive cancer cases were obtained from the Population-Based Cancer Registry of the AMB database, and population and mortality data from the National Administrative Department of Statistics (DANE). Crude and age-standardized incidence and mortality rates were calculated, both overall and sex-specific.
Results
During the study period, 11,815 incident cancer cases were recorded, excluding non-melanoma skin cancer. Age-standardized incidence rates per 100,000 person-years were 173.6 in men and 179.6 in women. The leading sites were prostate, stomach, and colorectal in men, and breast, thyroid, and colorectal in women. The age-standardized mortality rates were 117.56 per 100,000 man-years and 89.91 per 100,000 woman-years.
Conclusion
Incidence and mortality rates for most sites are higher than those observed in the previous five-year periods. PBCRs are the main cancer surveillance tool and are essential for formulating and evaluating public cancer-control policies.
Helio Caballero Rojas, Autonomous University of Bucaramanga
https://orcid.org/0000-0002-9100-1871
Autonomous University of Bucaramanga, Grupo de investigación Estudio Genético de Enfermedades Complejas, Bucaramanga, Colombia.
Autonomous University of Bucaramanga, Registro Poblacional de Cáncer del Área Metropolitana de Bucaramanga, Bucaramanga, Colombia.
Claudia Milena Hormiga Sánchez , Autonomous University of Bucaramanga
https://orcid.org/0000-0002-8723-666XAutonomous University of Bucaramanga, Grupo de investigación Estudio Genético de Enfermedades Complejas, Bucaramanga, Colombia.
Autonomous University of Bucaramanga, Registro Poblacional de Cáncer del Área Metropolitana de Bucaramanga, Bucaramanga, Colombia.
Claudia Janeth Uribe Pérez , Autonomous University of Bucaramanga
https://orcid.org/0000-0002-6640-5938
Autonomous University of Bucaramanga, Grupo de investigación Estudio Genético de Enfermedades Complejas, Bucaramanga, Colombia.
Autonomous University of Bucaramanga, Registro Poblacional de Cáncer del Área Metropolitana de Bucaramanga, Bucaramanga, Colombia.
Erika Eliana Meza Duran , Autonomous University of Bucaramanga
https://orcid.org/0009-0009-7806-7882
Universidad Autónoma de Bucaramanga, Registro Poblacional de Cáncer del Área Metropolitana de Bucaramanga, Bucaramanga, Colombia.
1. Schlander M, van Harten W, Retèl VP, Pham PD, Vancoppenolle JM, Ubels J, et al. The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions. Lancet Oncol. 2024;25(4):e152-e163. https://doi.org/10.1016/S1470-2045(23)00636-8 PMid:38547899
2. Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465-472. https://doi.org/10.1001/jamaoncol.2022.7826 PMid:36821107 PMCid:PMC9951101
3. Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029-3030. https://doi.org/10.1002/cncr.33587 PMid:34086348
4. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. https://doi.org/10.3322/caac.21834 PMid:38572751
5. Wild CP, Weiderpass E, Stewart BW, editors. World Cancer Report: Cancer Research for Cancer Prevention. Lyon: International Agency for Research on Cancer; 2020. Available from: https://publications.iarc.fr/586
6. Star J, Bandi P, Nargis N, Islami F, Yabroff KR, Minihan AK, et al. Updated review of major cancer risk factors and screening test use in the United States, with a focus on changes during the COVID-19 pandemic. Cancer Epidemiol Biomarkers Prev. 2023;32(7):879-888. https://doi.org/10.1158/1055-9965.EPI-23-0114 PMid:37129858
7. Martinez R, Lloyd-Sherlock P, Soliz P, Ebrahim S, Vega E, Ordunez P, et al. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study. Lancet Glob Health. 2020;8(4):e511-e523. https://doi.org/10.1016/S2214-109X(20)30035-8 PMid:32199120
8. Fadelu T, Rebbeck TR. The rising burden of cancer in low- and middle-human development index countries. Cancer. 2021;127(16):2864-2866. https://doi.org/10.1002/cncr.33586 PMid:34086352
9. Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2023;2(1):e000049. https://doi.org/10.1136/bmjonc-2023-000049 PMid:39886513 PMCid:PMC11235000
10. Piñeros M, Saraiya M, Baussano I, Bonjour M, Chao A, Bray F. The role and utility of population-based cancer registries in cervical cancer surveillance and control. Prev Med. 2021;144:106237. https://doi.org/10.1016/j.ypmed.2020.106237 PMid:33678223 PMCid:PMC7957339
11. Piñeros M, Znaor A, Mery L, Bray F. A global cancer surveillance framework within noncommunicable disease surveillance: making the case for population-based cancer registries. Epidemiol Rev. 2017;39(1):161-169. https://doi.org/10.1093/epirev/mxx003 PMid:28472440
12. Instituto Nacional de Cancerología. Sistema de Información de Cáncer en Colombia - SICC. Bogotá: Instituto Nacional de Cancerología. Available from: https://www.infocancer.co
13. Congreso de Colombia. Diario Oficial. Bogotá, D.C.: 2010. Ley 1384 de 2010, por la cual se establecen las acciones para la atención integral del cáncer en Colombia (Ley Sandra Ceballos). Available from: https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=39368
14. Congreso de la República. Congreso de Colombia. Bogotá, D.C.: 2023. Ley 2291 de 2023: por medio de la cual se transforma la naturaleza jurídica del Instituto Nacional de Cancerología Empresa Social del Estado, se define su objeto, funciones, estructura y régimen legal. Available from: https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=204543
15. Hormiga-Sánchez CM, Uribe-Pérez CJ, Meza-Durán EE. Registro poblacional de cáncer del Área Metropolitana de Bucaramanga: veinticinco años de trayectoria. MedUNAB. 2025;27(3):351-360. https://doi.org/10.29375/01237047.4708
16. Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, et al. Cancer incidence in five continents. Vol. XI. Lyon: International Agency for Research on Cancer; 2021. Available from: https://publications.iarc.who.int/597
17. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods part II. Completeness. Eur J Cancer. 2009;45(5):756-764. https://doi.org/10.1016/j.ejca.2008.11.033 PMid:19128954
18. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Registros de cáncer: principios y métodos. Lyon: International Agency for Research on Cancer; 1995. Available from: https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Scientific-Publications/Registros-De-C%C3%A1ncer-Principios-Y-M%C3%A9todos-1995
19. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), 2016 version. Geneva: WHO; 2016. Available from: https://icd.who.int/browse10/2016/en
20. Centers for Disease Control and Prevention. Registry Plus Link Plus, version 2.0. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2007. Available from: https://www.cdc.gov/national-program-cancer-registries/registry-plus/link-plus.html
21. International Association of Cancer Registries. CanReg5, version 5.00.44k. Lyon: IACR; 2023. Available from: https://www.iacr.com.fr/CanReg5/
22. DANE Proyecciones de población. Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/proyecciones-de-poblacion
23. Boniol M, Heanue M. In: Cancer incidence in five continents. Vol. IX. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, editors. Lyon: International Agency for Research on Cancer; 2007. Age-standardisation and denominators; pp. 99-101.
24. Uribe C, Osma S, Herrera V. Cancer incidence and mortality in the Bucaramanga metropolitan area, 2003-2007. Colomb Med (Cali) 2012;43(4):290-297. https://doi.org/10.25100/cm.v43i4.1196 PMid:24893302 PMCid:PMC4001965
25. Uribe PCJ, Serrano-Gómez S, Hormiga SCM. Incidencia y mortalidad por cáncer en Bucaramanga, Colombia. 2008-2012. Colomb Med (Cali) 2018;49(1):73-80. https://doi.org/10.25100/cm.v49i1.3632 PMid:29983466 PMCid:PMC6018816
26. Arias-Ortiz N, Rodríguez-Betancourt JD. Trends in cancer incidence and mortality in Manizales, Colombia, 2008-2017. Colomb Med (Cali) 2022;53(1):e2044920. https://doi.org/10.25100/cm.v53i1.4920 PMid:36415595 PMCid:PMC9651083
27. Bravo LE, Garcia LS, Collazos P, Carrascal E, Grillo-Ardila EK, Millan E, et al. Epidemiología del cáncer en Cali, 60 años de experiencia. Colomb Med (Cali) 2022;53(1):e2005050. https://doi.org/10.25100/cm.v53i1.5050 PMid:36415596 PMCid:PMC9651077
28. Yépez CMC, Bravo GLM, Jurado FD, Mena HJ, Casas HM. Incidence and mortality by cancer in the Pasto municipality, Colombia. 2013-2017. Colomb Med (Cali) 2022;53(1):e2054952. https://doi.org/10.25100/cm.v53i1.4952 PMid:36415600 PMCid:PMC9651136
29. Sundar R, Nakayama I, Markar SR, Shitara K, Van Laarhoven HWM, Janjigian YY, et al. Gastric cancer. Lancet. 2025;405(10494):2087-2102. https://doi.org/10.1016/S0140-6736(25)00052-2 PMid:40319897
30. Mamun TI, Younus S, Rahman MH. Gastric cancer-Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: an updated review. Cancer Treat Res Commun. 2024;41:100845. https://doi.org/10.1016/j.ctarc.2024.100845 PMid:39357127
31. Wiesner-Ceballos C, Puerto D, Diaz-Casas S, Sánchez O, Hernando-Murillo R, Bravo LE. Políticas basadas en la evidencia científica: el caso del control del cáncer de mama en Colombia. Rev colomb cancerol. 2020;24(3):98-107. https://doi.org/10.35509/01239015.261
32. Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 2021;18(10):663-672. https://doi.org/10.1038/s41571-021-00514-z PMid:34079102
33. Duarte C, Salazar A, Strasser-Weippl K, de Vries E, Wiesner C, Arango-Gutiérrez A, et al. Breast cancer in Colombia: a growing challenge for the healthcare system. Breast Cancer Res Treat. 2021;186(1):15-24. https://doi.org/10.1007/s10549-020-06091-6 PMid:33611666
34. Congreso de la República. Diario Oficial. Bogotá, D.C.: 2015. Ley Estatutaria 1751 de 2015: por medio de la cual se regula el derecho fundamental a la salud y se dictan otras disposiciones. Available from: https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=60733
35. Ministerio de Salud y Protección Social. Ministerio de Salud y Protección Social. Bogotá, D.C.: 2018. Resolución 3280 de 2018: por medio de la cual se adoptan los lineamientos técnicos y operativos de la Ruta Integral de Atención para la Promoción y Mantenimiento de la Salud y la Ruta Integral de Atención en Salud para la Población Materno Perinatal y se establecen las directrices para su operación. Available from: https://www.minsalud.gov.co/Normatividad_Nuevo/Resoluci%C3%B3n%20No.%203280%20de%2020183280.pdf
36. Song M. Global epidemiology and prevention of colorectal cancer. Lancet Gastroenterol Hepatol. 2022;7(7):588-590. https://doi.org/10.1016/S2468-1253(22)00089-9 PMid:35397797
37. James ND, Tannock I, N'Dow J, Feng F, Gillessen S, Ali SA, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683-1722. https://doi.org/10.1016/S0140-6736(24)00651-2 PMid:38583453 PMCid:PMC7617369
38. Bermedo-Carrasco S, Waldner CL. The role of socio-demographic factors in premature cervical cancer mortality in Colombia. BMC Public Health. 2016;16:981. https://doi.org/10.1186/s12889-016-3645-1 PMid:27628314 PMCid:PMC5024424
39. Chayo I, Uribe PCJ, de Vries E, Pinheiro PS. The impact of health insurance affiliation and socioeconomic status on cervical cancer survival in Bucaramanga, Colombia. Cancer Epidemiol. 2023;85:102375. https://doi.org/10.1016/j.canep.2023.102375 PMid:37150101
40. García-López T, León-Hernández J, García-Perdomo H, Pacheco R. Evaluación de un programa de detección temprana de cáncer cervicouterino en Colombia. Rev Colomb Cancerol. 2017;21(3):143-151. https://doi.org/10.1016/j.rccan.2017.09.001
41. Arrivillaga M, Ruiz MD, Medina M. Atención en salud de mujeres con lesiones precursoras de cáncer de cuello uterino: evidencia cualitativa de la fragmentación del sistema de salud en Colombia. Rev Gerenc Polit Salud. 2019;18(37):1-20. https://doi.org/10.11144/Javeriana.rgps18-37.asml
42. Arrossi S, Paolino M, Thouyaret L, Laudi R, Campanera A. Evaluation of scaling-up of HPV self-collection offered by community health workers at home visits to increase screening among socially vulnerable under-screened women in Jujuy Province, Argentina. Implement Sci. 2017;12(1):17. https://doi.org/10.1186/s13012-017-0548-1 PMid:28193227 PMCid:PMC5307871
43. Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Glob Health. 2015;3(2):e85-e94. https://doi.org/10.1016/S2214-109X(14)70354-7 PMid:25617202 PMCid:PMC13239314
44. Torrado-García LM, Martínez-Vega RA, Rincon-Orozco B. A novel strategy for cervical cancer prevention using cervical-vaginal self-collected samples shows high acceptability in women living in low-income conditions from Bucaramanga, Colombia. Int J Womens Health. 2020;12:1197-1204. https://doi.org/10.2147/IJWH.S265130 PMid:33364853 PMCid:PMC7751441
45. Dartibale CB, Prado GDC, Carobeli LR, Meirelles LEDF, Damke GMZF, Damke E, et al. Recent HPV self-sampling use for cervical cancer screening in Latin America and Caribbean: a systematic review. Front Oncol. 2022;12:948471. https://doi.org/10.3389/fonc.2022.948471 PMid:36338730 PMCid:PMC9627290
46. Narvaez L, Viviano M, Dickson C, Jeannot E. The acceptability of HPV vaginal self-sampling for cervical cancer screening in Latin America: a systematic review. Public Health Pract (Oxf) 2023;6:100417. https://doi.org/10.1016/j.puhip.2023.100417 PMid:37564780 PMCid:PMC10410574
47. Nishimura H, Yeh PT, Oguntade H, Kennedy CE, Narasimhan M. HPV self-sampling for cervical cancer screening: a systematic review of values and preferences. BMJ Glob Health. 2021;6(5):e003743. https://doi.org/10.1136/bmjgh-2020-003743 PMid:34011537 PMCid:PMC8137189
Downloads
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use